Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reactions using 'double sensitization' with two antigenically distinct rat reagins.

× No keyword cloud information.

18 in total

1. Proteolytic enzymes.

Authors: B S HARTLEY
Journal: Annu Rev Biochem Date: 1960 Impact factor: 23.643

2. Biologic properties of rat antibodies. 3. Histamine release mediated by two classes of antibodies.

Authors: H C Morse; K F Austen; K J Bloch
Journal: J Immunol Date: 1969-02 Impact factor: 5.422

3. Disodium cromoglycate. Activity in three in vitro models of the immediate hypersensitivity reaction in lung.

Authors: P Sheard; A M Blair
Journal: Int Arch Allergy Appl Immunol Date: 1970

4. Disodium cromoglycate, an inhibitor of mas cell degranulation and histamine release induced by phospholipase A.

Authors: T S Orr; J S Cox
Journal: Nature Date: 1969-07-12 Impact factor: 49.962

5. Effect of disodium cromoglycate on certain passive cutaneous anaphylactic reactions.

Authors: M Lopez; K J Bloch
Journal: J Immunol Date: 1969-12 Impact factor: 5.422

6. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate. I. Cutaneous reactions induced by an anti-DNP 7S-gamma-2 antibody.

Authors: T S Orr; J Gwilliam; J S Cox
Journal: Immunology Date: 1970-09 Impact factor: 7.397

7. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms.

Authors: J S Cox
Journal: Nature Date: 1967-12-30 Impact factor: 49.962

8. Antigen induced release of histamine and SRS-A from human lung passively sensitized with reaginic serum.

Authors: P Sheard; P G Killingback; A M Blair
Journal: Nature Date: 1967-10-21 Impact factor: 49.962

9. Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement.

Authors: E L Becker; K F Austen
Journal: J Exp Med Date: 1966-09-01 Impact factor: 14.307

10. Anaphylaxis in chopped guinea pig lung. I. Effect of peptidase substrates and inhibitors.

Authors: K F AUSTEN; W E BROCKLEHURST
Journal: J Exp Med Date: 1961-03-01 Impact factor: 14.307

20 in total

1. Sodium cromoglycate in nocturnal asthma.

Authors: A D Morgan; J J Connaughton; J R Catterall; C M Shapiro; N J Douglas; D C Flenley
Journal: Thorax Date: 1986-01 Impact factor: 9.139

2. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate.

Authors: D S Thomson; D P Evans
Journal: Clin Exp Immunol Date: 1973-04 Impact factor: 4.330

3. Studies of reversed anaphylaxis in the perfused guinea-pig lung.

Authors: I Broder; R Baumal
Journal: Immunology Date: 1972-04 Impact factor: 7.397

4. Antigen-induced hypersensitivity of the bronchial system and the influence of disodium cromoglycate.

Authors: I Zimmermann; W T Ulmer
Journal: Pneumonologie Date: 1976-04-09

5. Protective effect of drugs on bronchoconstriction induced by sulphur dioxide.

Authors: W C Tan; E Cripps; N Douglas; M F Sudlow
Journal: Thorax Date: 1982-09 Impact factor: 9.139

6. Effect of lignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma.

Authors: W M Tullett; K R Patel; K E Berkin; J W Kerr
Journal: Thorax Date: 1982-10 Impact factor: 9.139

7. Treatment of pyoderma gangrenosum with disodium cromoglycate.

Authors: B Saffouri; B M Hom; J M Mertesdorf; J E Gardiner
Journal: Dig Dis Sci Date: 1984-02 Impact factor: 3.199

8. Effect of disodium cromoglycate (Intal) on antigen-induced histamine release from passively sensitized human lung in vitro.

Authors: H Morr
Journal: Lung Date: 1978 Impact factor: 2.584

9. Disodium cromoglycate in the treatment of chronic proctitis.

Authors: R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal: Gut Date: 1975-07 Impact factor: 23.059

10. Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.

Authors: Samia Yazid; Egle Solito; Helen Christian; Simon McArthur; Nicolas Goulding; Roderick Flower
Journal: Biochem Pharmacol Date: 2009-03-24 Impact factor: 5.858